AI
Alzheon, Inc.
AgeTech
About
Alzheon, Inc. is a biopharmaceutical company focused on developing novel therapeutics for Alzheimer's disease and other neurodegenerative conditions affecting aging populations. The company leverages advanced drug discovery platforms to create targeted treatments that address the underlying biological mechanisms of cognitive decline and neurological disorders.
Is this your company?
Claim this listing to update your profile, add your logo, and reach buyers searching for AgeTech.
Key facts
FundingPrivate
SectorAgeTech
Are you Alzheon, Inc.?
Claim your profile
Upgrade to Premium for a full profile, featured badge, logo, and contact button.
Get premium listing →